武汉云克隆科技股份有限公司

衰老关键蛋白1(FBLN1)单克隆抗体

Monoclonal Antibody to Fibulin 1 (FBLN1)

  • 衰老关键蛋白1(FBLN1)单克隆抗体产品包装(模拟)
  • 衰老关键蛋白1(FBLN1)单克隆抗体产品包装(模拟)
  • 衰老关键蛋白1(FBLN1)单克隆抗体DAB staining on IHC-P; Samples: Mouse Testis Tissue; Primary Ab: 30µg/ml Mouse Anti-Mouse FBLN1 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 衰老关键蛋白1(FBLN1)单克隆抗体DAB staining on IHC-P;
    Samples: Mouse Uterus Tissue;
    Primary Ab: 30µg/ml Mouse Anti-Mouse FBLN1 Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • 衰老关键蛋白1(FBLN1)单克隆抗体AF488 staining on IF;
    Sample: Hepa1-6 cell
    Primary Ab: 20µg/ml Mouse Anti-Mouse FBLN1 Antibody
    Second Ab: 2μg/ml AF488-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu11)
  • MAC472Mu21.jpgFigure. Western Blot; Sample: Recombinant FBLN1, Mouse.
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对FBLN1的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别FBLN1。

用法

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Mus musculus (Mouse，小鼠)应用(仅供研究使用，不用于临床诊断！)
RPC472Mu01衰老关键蛋白1(FBLN1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC472Mu01衰老关键蛋白1(FBLN1)多克隆抗体WB; IHC; ICC; IP.
LAC472Mu71衰老关键蛋白1(FBLN1)多克隆抗体(生物素标记)WB; IHC; ICC.
MAC472Mu22衰老关键蛋白1(FBLN1)单克隆抗体WB; IHC; ICC; IP.
MAC472Mu21衰老关键蛋白1(FBLN1)单克隆抗体WB; IHC; ICC; IP.
LAC472Mu72衰老关键蛋白1(FBLN1)单克隆抗体(生物素标记)WB; IHC; ICC.
SEC472Mu衰老关键蛋白1(FBLN1)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMC472Mu衰老关键蛋白1(FBLN1)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
PSC472Mu01衰老关键蛋白1(FBLN1)抗体对ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSC472Mu01衰老关键蛋白1(FBLN1)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
Clin Exp Metastasis.Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734]
Proteomics Clinical ApplicationsComparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509]
PROTEOMICS - Clinical ApplicationsComparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients.[pubmed:26680509]
ENVIRONMENTAL RESEARCHExploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421]